Literature DB >> 10482567

Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus.

I M Rouzine1, J M Coffin.   

Abstract

To study the mechanism of evolution of the human immunodeficiency virus (HIV) protease gene (pro), we analyzed a database of 213 pro sequences isolated from 11 HIV type 1-infected patients who had not been treated with protease inhibitors. Variation in pro is restricted to rare variable bases which are highly diverse and differ in location among individuals; an average variable base appears in about 16% of individuals. The average intrapatient distance per individual variable site, 27%, is similar for synonymous and nonsynonymous sites, although synonymous sites are twice as abundant. The latter observation excludes selection for diversity as an important, permanently acting factor in the evolution of pro and leaves purifying selection as the only kind of selection. Based on this, we developed a model of evolution, both within individuals and along the transmission chain, which explains variable sites as slightly deleterious mutants slowly reverting to the better-fit variant during individual infection. In the case of a single-source transmission, genetic bottlenecks at the moment of transmission effectively suppress selection, allowing mutants to accumulate along the transmission chain to high levels. However, even very rare coinfections from independent sources are, as we show, able to counteract the bottleneck effect. Therefore, there are two possible explanations for the high mutant frequency. First, the frequency of coinfection in the natural host population may be quite low. Alternatively, a strong variation of the best-adapted sequence between individuals could be caused by a combination of an immune response present in early infection and coselection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482567      PMCID: PMC112834          DOI: 10.1128/JVI.73.10.8167-8178.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Rapid generation of sequence variation during primary HIV-1 infection.

Authors:  S Pang; Y Shlesinger; E S Daar; T Moudgil; D D Ho; I S Chen
Journal:  AIDS       Date:  1992-05       Impact factor: 4.177

Review 2.  The fastest genome evolution ever described: HIV variation in situ.

Authors:  S Wain-Hobson
Journal:  Curr Opin Genet Dev       Date:  1993-12       Impact factor: 5.578

3.  The fidelity of Taq polymerase catalyzing PCR is improved by an N-terminal deletion.

Authors:  W M Barnes
Journal:  Gene       Date:  1992-03-01       Impact factor: 3.688

4.  Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses.

Authors:  S L Liu; T Schacker; L Musey; D Shriner; M J McElrath; L Corey; J I Mullins
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  Intrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions.

Authors:  F K Yoshimura; K Diem; G H Learn; S Riddell; L Corey
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous.

Authors:  T F Wolfs; J J de Jong; H Van den Berg; J M Tijnagel; W J Krone; J Goudsmit
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Tracking members of the simian immunodeficiency virus deltaB670 quasispecies population in vivo at single-cell resolution.

Authors:  T A Reinhart; M J Rogan; A M Amedee; M Murphey-Corb; D M Rausch; L E Eiden; A T Haase
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  HIV-1 patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic.

Authors:  D Pieniazek; L M Janini; A Ramos; A Tanuri; M Schechter; J M Peralta; A C Vicente; N K Pieniazek; G Schochetman; M A Rayfield
Journal:  Emerg Infect Dis       Date:  1995 Jul-Sep       Impact factor: 6.883

9.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo.

Authors:  S L Lamers; J W Sleasman; J X She; K A Barrie; S M Pomeroy; D J Barrett; M M Goodenow
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  20 in total

1.  Linkage disequilibrium test implies a large effective population number for HIV in vivo.

Authors:  I M Rouzine; J M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 2.  Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology.

Authors:  I M Rouzine; A Rodrigo; J M Coffin
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

3.  The solitary wave of asexual evolution.

Authors:  Igor M Rouzine; John Wakeley; John M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

4.  Evolution of human immunodeficiency virus under selection and weak recombination.

Authors:  I M Rouzine; J M Coffin
Journal:  Genetics       Date:  2005-03-02       Impact factor: 4.562

5.  Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups.

Authors:  Stéphane Hué; Deenan Pillay; Jonathan P Clewley; Oliver G Pybus
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

6.  The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus.

Authors:  James B Whitney; Maureen Oliveira; Mervi Detorio; Yongjun Guan; Mark A Wainberg
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Design requirements for interfering particles to maintain coadaptive stability with HIV-1.

Authors:  Igor M Rouzine; Leor S Weinberger
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

8.  Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.

Authors:  Guido van Marle; Deirdre L Church; Kali D Nunweiler; Kris Cannon; Mark A Wainberg; M John Gill
Journal:  Retrovirology       Date:  2010-09-13       Impact factor: 4.602

9.  Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance.

Authors:  Xiaobin Lu; Qiao Yu; Gwendolyn K Binder; Ziping Chen; Tatiana Slepushkina; John Rossi; Boro Dropulic
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Authors:  Amit Kapoor; Morris Jones; R W Shafer; Soo-Yon Rhee; Powel Kazanjian; Eric L Delwart
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.